(CGDV) Capital Dividend Value - Ratings and Ratios
Equity, Large-Cap, Dividend, U.S
| Risk via 10d forecast | |
|---|---|
| Volatility | 13.8% |
| Value at Risk 5%th | 22.7% |
| Relative Tail Risk | 0.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 7.69 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.374 |
| Beta | 0.807 |
| Beta Downside | 0.852 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.28% |
| Mean DD | 1.72% |
| Median DD | 0.89% |
Description: CGDV Capital Dividend Value October 14, 2025
CGDV is a non-diversified ETF that targets large-cap U.S. equities with a proven history of paying dividends, allocating at least 80% of its assets to companies with market capitalizations above $4 billion. The fund may allocate up to 10% to dividend-paying stocks of large, non-U.S. companies.
Key metrics (as of Q3 2024) include an expense ratio of 0.28% and a trailing 12-month dividend yield around 2.6%. The top holdings are heavily weighted toward financials (≈30%) and consumer staples (≈20%), sectors that tend to benefit from a stable interest-rate environment and resilient consumer demand. The fund’s performance is sensitive to Fed policy, as higher rates can compress equity valuations while also supporting higher dividend yields for mature companies.
If you want a more granular look at CGDV’s valuation profile and risk characteristics, consider checking out ValueRay’s analytical dashboard for this ETF.
CGDV ETF Overview
| Market Cap in USD | 24,614m |
| Category | Large Value |
| TER | 0.33% |
| IPO / Inception | 2022-02-22 |
| Return 12m vs S&P 500 | 4.97% |
| Analyst Rating | - |
CGDV Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.33% |
| Yield on Cost 5y | 2.40% |
| Yield CAGR 5y | 32.76% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
CGDV Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 23.70% |
| CAGR/Max DD Calmar Ratio | 1.66 |
| CAGR/Mean DD Pain Ratio | 13.81 |
| Current Volume | 6483k |
| Average Volume | 4077.8k |
What is the price of CGDV shares?
Over the past week, the price has changed by -1.45%, over one month by -0.14%, over three months by +3.61% and over the past year by +17.95%.
Is CGDV a buy, sell or hold?
What are the forecasts/targets for the CGDV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.4 | 16.9% |
CGDV Fundamental Data Overview November 21, 2025
Beta = 0.88
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 24.61b USD (24.61b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 24.61b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 24.61b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.99% (E(24.61b)/V(24.61b) * Re(8.99%) + (debt-free company))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CGDV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle